All financings
COMPANY TRANSACTIONS

Yarrow Bioscience, Inc.

YARWNasdaqBiotechnology

Deal details

1 transaction in the database

TRANSACTION REPORT · SEC DISCLOSURES

Deal notes

Not yet verifiedClosing confirmation

Closing has not been confirmed in the reviewed sources. This record does not establish that funding was received.

Gross proceeds$172.5M
Offering price$26.00
Discount to prior close8.6%
Warrant coverage—

Transaction overview

01

Yarrow Bioscience, Inc. disclosed a $172.5M underwritten public offering at $26.00 per share. Jefferies LLC, TD Securities (USA) LLC, Guggenheim Securities, LLC, LifeSci Capital LLC participated in the financing.

Financing type
Underwritten Public Offering
Announcement date
—
SEC disclosure date
Sep 11, 2026
Agreement date
Sep 10, 2026
Pricing date
Sep 10, 2026
Closing date
—
Filing date
Sep 14, 2026
Status
Priced
Market cap before SEC disclosure
$24.4M
Prior closing price
$28.44
Raise as % of market cap
706.9%

Market data · FMP

Historical market cap
$24,401,520
Market date
Sep 10, 2026
Closing price
$28.44
Latest reported shares outstanding
17,196
Latest reported float shares
—
Share-data date
Sep 29, 2026

Market cap and closing price are from FMP for the date shown. Shares are FMP’s latest available snapshot, dated separately. Updated Sep 30, 2026.

Financial Modeling Prep ↗

Financing terms

02

Equity

Common shares issued
6,634,615
Price per share
$26.00
Pre-funded warrants
—
Pre-financing shares disclosed in filing
—
Shares outstanding after financing
—

Fees & transaction economics

03
Placement agent / underwriting fee
—
Agent fee amount
—
Management fee
—
Other offering expenses (estimated)
—
Net proceeds (estimated)
$161.8M
Net proceeds as % of gross
93.8%

Fee amounts reflect disclosed inputs. Unknown expense components are not assumed to be zero.

Totals include the fully exercised 865,384-share option. Closing was still described as expected in the September 14 filing.

Transaction participants

04
Investor names: —

Source documents

05

SEC filings, exhibits and attributed market data. The report separates disclosed facts, calculated metrics, and unknown terms.

424B5 · Yarrow Bioscience, Inc.SEC filing · Sep 11, 2026
Open source ↗
8-K · Yarrow Bioscience, Inc.SEC filing · Sep 14, 2026
Open source ↗
EX-1.1 · Yarrow Bioscience, Inc.SEC filing · Sep 14, 2026
Open source ↗
EX-5.1 · Yarrow Bioscience, Inc.SEC filing · Sep 14, 2026
Open source ↗
FMP historical market data · YARWMarket data · Sep 10, 2026
Open source ↗
SEC deal terms · FMP market data where available · Initial research sample, not complete market coverage. AI-assisted source review; original evidence is available in each report. Names and tickers reflect the transaction date. A dash (—) means the value is unavailable.